Breast and Gynecologic Cancer

The Breast and Gynecologic Cancer Research Group (BGCRG) conducts and fosters the development of research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and precursor conditions related to these cancers.

Read more About the Breast and Gynecologic Cancer Research Group.

Staff

Funding Opportunities

Grants

Clinical Trials

Publications

Cancer Prevention Clinical Trials Network (CP-CTNet)

A medical professional shakes hands with a patient seated on a examination table.

Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.

HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network

Seeks to conduct pragmatic clinical trials evaluating the effectiveness of clinically proven interventions to optimize the cervical cancer screening, management, and precancer treatment cascade for WLWH.

The National Cancer Institute (NCI)’s Cervical Cancer ‘Last Mile’ Initiative

The 'Last Mile'  is a public-private partnership bringing together federal agencies, industry partners, and professional societies to contribute evidence about the accuracy and clinical effectiveness of self-sampling-based HPV testing for cervical cancer screening.

US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)

Partnership Centers will focus on improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals.

News and Events

Press Release: Enrollment in TMIST Breast Cancer Screening Trial Surpasses Halfway Mark; Recruitment of Women from Diverse Backgrounds is Key to Success
Date Posted: March 25, 2022

Studies Focus on Testing Family Members of Cancer Gene Carriers
Date Posted: November 29, 2021

Study Seeks to Prevent Cancer and Extend Quality of Life for Women at Increased Genetic Risk of Ovarian Cancer
Date Posted: September 7, 2021

Cancer Prevention and Screening: Progress Made and Progress to Come
Date Reviewed: January 26, 2022

Making Informed Choices on Incorporating Chemoprevention Into Breast Care: Q & A with Dr. Katherine Crew on the MiCHOICE Trial
Date Posted: December 8, 2020